General MedicationsSOLUTIONGeneric
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
Standard Dose
2000MG/10ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 219271 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient CYCLOPHOSPHAMIDE Form and strength INJECTION;SOLUTION - 2000MG/10ML Sponsor HETERO LABS LIMITED Submission history Latest submission status date: 2026-01-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 219271 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient CYCLOPHOSPHAMIDE Form and strength INJECTION;SOLUTION - 2000MG/10ML Sponsor HETERO LABS LIMITED Submission history Latest submission status date: 2026-01-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.